Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.7017 USD | -0.44% | +3.04% | -2.54% |
08/03 | Galecto, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | Galecto Shares Climb After Bone Marrow Disease Treatment Trial Yields Positive Results | MT |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 19.02M 1.59B |
---|---|---|---|---|---|
Net income 2024 * | -32M -2.67B | Net income 2025 * | -52M -4.34B | EV / Sales 2024 * | - |
Net cash position 2024 * | 18.1M 1.51B | Net cash position 2025 * | 71.7M 5.99B | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.58
x | P/E ratio 2025 * |
-0.39
x | Employees | 13 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 88.19% |
1 day | -0.44% | ||
1 week | +3.04% | ||
Current month | -10.04% | ||
1 month | -10.04% | ||
3 months | +1.67% | ||
6 months | +31.43% | ||
Current year | -2.54% |
Managers | Title | Age | Since |
---|---|---|---|
Hans Schambye
CEO | Chief Executive Officer | 59 | 01/11/01 |
Jonathan Freve
DFI | Director of Finance/CFO | 46 | 01/20/01 |
Anders Pedersen
COO | Chief Operating Officer | 64 | 01/20/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 65 | 01/20/01 | |
Chau Khuong
BRD | Director/Board Member | 48 | 01/18/01 |
David Shapiro
BRD | Director/Board Member | 69 | 19/20/19 |
Date | Price | Change | Volume |
---|---|---|---|
29/24/29 | 0.7017 | -0.44% | 96,651 |
26/24/26 | 0.7048 | +5.37% | 119,427 |
25/24/25 | 0.6689 | -0.31% | 26,490 |
24/24/24 | 0.671 | -4.22% | 75,622 |
23/24/23 | 0.7006 | +2.88% | 107,064 |
Delayed Quote Nasdaq, April 30, 2024 at 02:00 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.54% | 19.02M | |
-2.63% | 102B | |
+1.62% | 96.29B | |
+1.46% | 22.18B | |
-16.67% | 21.2B | |
-8.58% | 18.31B | |
-38.74% | 17.38B | |
-13.21% | 16.36B | |
+5.41% | 13.97B | |
+33.57% | 12.17B |
- Stock Market
- Equities
- GLTO Stock